Paper41258746
Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world Study.
Yu Y and 14 others. Acta Derm Venereol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world Study. Papers, record 41258746. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41258746
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Short-term Abrocitinib Combined with Medicated Topical Therapy Provides Rapid Improvement in Pruritus in Elderly Patients with Moderate-to-severe Atopic Dermatitis: A Retrospective, Observational Real-world Study.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pruritus | Major topic |
| Dermatitis, Atopic | Major topic |
| Pyrimidines | Major topic |
| Sulfonamides | Major topic |
| Antipruritics | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Janus Kinase Inhibitors | Major topic |
| Humans | |
| Male | |
| Female | |
| Aged | |
| Retrospective Studies | |
| Treatment Outcome | |
| Severity of Illness Index | |
| Time Factors | |
| Administration, Cutaneous | |
| Aged, 80 and over | |
| Drug Therapy, Combination | |
| Administration, Oral | |
| Age Factors | |
| Drug Administration Schedule |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33491094 | Treat-to-Target in Atopic Dermatitis: An International Consensus on a Set of Core Decision Points for Systemic Therapies. | Acta Derm Venereol | 2021 | https://conductscience.org/library/papers/33491094 | PubMed |
| 2 | 34072076 | Immunological Aspects of Skin Aging in Atopic Dermatitis. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34072076 | PubMed |
| 3 | 18837700 | Clinical analyses of atopic dermatitis in the aged. | J Dermatol | 2008 | https://conductscience.org/library/papers/18837700 | PubMed |
| 4 | 33491884 | Update "Systemic treatment of atopic dermatitis" of the S2k-guideline on atopic dermatitis. | J Dtsch Dermatol Ges | 2021 | https://conductscience.org/library/papers/33491884 | PubMed |
| 5 | 27825969 | An Integrated Model of Atopic Dermatitis Biomarkers Highlights the Systemic Nature of the Disease. | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/27825969 | PubMed |
| 6 | 35170524 | Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey. | Dermatitis | 2022 | https://conductscience.org/library/papers/35170524 | PubMed |
| 7 | 30895603 | Atopic dermatitis in the elderly: a review of clinical and pathophysiological hallmarks. | Br J Dermatol | 2020 | https://conductscience.org/library/papers/30895603 | PubMed |
| 8 | 22113882 | Prevalence and risk factors for atopic dermatitis: a cross-sectional study of 6,453 Korean preschool children. | Acta Derm Venereol | 2012 | https://conductscience.org/library/papers/22113882 | PubMed |
| 9 | 38705585 | Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment. | J Dermatolog Treat | 2024 | https://conductscience.org/library/papers/38705585 | PubMed |
| 10 | 34406619 | Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program. | Am J Clin Dermatol | 2021 | https://conductscience.org/library/papers/34406619 | PubMed |
| 11 | 37953857 | Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis. | Clin Cosmet Investig Dermatol | 2023 | https://conductscience.org/library/papers/37953857 | PubMed |
| 12 | 34406366 | Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis: The JADE TEEN Randomized Clinical Trial. | JAMA Dermatol | 2021 | https://conductscience.org/library/papers/34406366 | PubMed |
| 13 | 31749264 | A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management. | J Eur Acad Dermatol Venereol | 2020 | https://conductscience.org/library/papers/31749264 | PubMed |
| 14 | 28390478 | Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/28390478 | PubMed |
| 15 | 38216802 | Targeted Systemic Therapies for Adults with Atopic Dermatitis: Selecting from Biologics and JAK Inhibitors. | Am J Clin Dermatol | 2024 | https://conductscience.org/library/papers/38216802 | PubMed |
| 16 | 38652379 | Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom. | Dermatol Ther (Heidelb) | 2024 | https://conductscience.org/library/papers/38652379 | PubMed |
| 17 | 38522931 | [RECOMMENDATION FOR ITCH ASSESSMENT FROM THE ATOPIC ITCH CONSENSUS MEETING (AICOM)]. | Arerugi | 2024 | https://conductscience.org/library/papers/38522931 | PubMed |
| 18 | 36890685 | Efficacy and safety of baricitinib treatment for moderate to severe atopic dermatitis in real-world practice in Japan. | J Dermatol | 2023 | https://conductscience.org/library/papers/36890685 | PubMed |
| 19 | 39598368 | Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39598368 | PubMed |
| 20 | 38724794 | Atopic Dermatitis: Managing the Itch. | Adv Exp Med Biol | 2024 | https://conductscience.org/library/papers/38724794 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| JAK1 | 3716 | PubTator's text mining | https://conductscience.org/library/genes/3716 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41258746
GET https://conductscience.org/api/papers/v1/41258746/references?page=2